Lebwohl, M. G., Sugarman, J., Pariser, D. M., Bagel, J., Trickett, C., Jacobson, A., & Israel, R. (2020). Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study. SKIN The Journal of Cutaneous Medicine, 4(5), s38. https://doi.org/10.25251/skin.4.supp.38